Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational studyXianchun Gao, Qingchuan Zhao, Yuanyuan Lu et al.|International Journal of Surgery|2023Cited by 15
Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort studyXianchun Gao, Yongzhan Nie, Gang Li et al.|The Lancet Regional Health - Western Pacific|2024Cited by 9
CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with Nab-PTX, S-1 and apatinib for the first-line treatment of stage IV gastric cancer (GC).Qiang Xue, Han Liang, Baogui Wang et al.|Journal of Clinical Oncology|2021Cited by 6
Evolution of HER2 expression after neoadjuvant therapy in locally advanced gastric cancerWeihua Gong, Hongming Liu, Yansong Dong et al.|iScience|2025Cited by 1
Impact of the HER2 Expression on Survival and Fluorouracil-Based Adjuvant Chemotherapeutic Benefits in Stage II/III Gastric Cancer: A Multicenter Observational StudyXianchun Gao, MAGIS Study Group, Lulu Zhao et al.|SSRN Electronic Journal|2022Cited by 0